Enhanced antitumor activitiy of trans(±)-1,2-Diaminocyclo- hexaneglutamatoplatinum(II) formulated with stealth liposome
Authors:
- 1 December 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 11 (24) , 5443-5447
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Liposome Formulations for Effective Administration of Lipophilic Malonatoplatinum(II) ComplexesJapanese Journal of Cancer Research, 2002
- The Role for Liposomal Drug Delivery in Molecular and Pharmacological Strategies to Overcome Multidrug ResistanceCancer and Metastasis Reviews, 2001
- Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumoursCancer Chemotherapy and Pharmacology, 2000
- Intraliposomal chemical activation patterns of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II) (L-NDDP)-a potential antitumour agentJournal of Microencapsulation, 2000
- Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor modelsAnti-Cancer Drugs, 1999
- Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing miceCancer Chemotherapy and Pharmacology, 1999
- In vivo antitumor activity of cis-bis-neodecanoato-trans- R,R-l,2-diaminocyclohexane platinum(II) formulated in long-circulating liposomesCancer Chemotherapy and Pharmacology, 1996
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proceedings of the National Academy of Sciences, 1991
- Toxicity and antitumor activity of cis-bis-carboxylato(trans-R,R-1,2-diaminocyclohexane) platinum(II) complexes entrapped in liposomesCancer Chemotherapy and Pharmacology, 1989
- Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexesChemico-Biological Interactions, 1989